Global oxycodone hydrochloride market is growing due to increasing product utilization to reduce the pain caused by radiation-induced oral mucositis by patients suffering from neck and head cancer and a rising number of surgical procedures.
Home>Industry Reports>Global Oxycodone Hydrochloride Market Assessment, Opportunities and Forecast, 2017-2031F
Global oxycodone hydrochloride market is projected to witness a CAGR of 5.1% during the forecast period 2024-2031, growing from USD 421.5 million in 2023 to USD 627.51 million in 2031F. The key factors, such as the surging prevalence of cancer and rising requirements by the healthcare sectors, including specialty clinics, hospitals, and ambulatory surgery centers, are accelerating the adoption of oxycodone hydrochloride, which, in turn, is boosting market growth. The hydrochloride salt of oxycodone, a semisynthetic opioid, and methyl ether of oxymorphone have antitussive and analgesic properties. The increasing preference for effective pain management solutions is one of the major significant drivers for market growth.
The market expansion is supported by the increasing old-age population, resulting in higher cases of severe pain. For instance, according to the World Health Organization (WHO) estimates, one in six individuals living across the world will be sixty years or older by the year 2030. By 2050, the population aged sixty and older will be approximately 2.1 billion. This increase will bolster the requirement for oxycodone hydrochloride as it is used for relieving acute and severe pain and the older population is more susceptible to suffering from various pain-related disorders. Thus, propelling the demand for the product and augmenting the global oxycodone hydrochloride market size.
Oxycodone hydrochloride, a moderately potent opioid analgesic aid in relieving severe to moderate pain and is obtained by the reaction of one molar equivalent of hydrochloric acid and oxycodone. The oxycodone binds with the mu-receptors present in the central nervous system and mimics the effects of endogenous opiates. The chemical is used as an active ingredient in various drugs including oxycodone hydrochloride capsules, Percodan, and Roxybond among others. Due to this, the demand for the chemical is rising from the medicine manufacturing sector, thus supporting the expansion of the market.
Increasing Prevalence of Cancer Supports Global Oxycodone Hydrochloride Market Growth
The addition of oxycodone hydrochloride to conventional therapy aids in effectively controlling the pain from radiation-induced oral mucositis as compared to conventional therapy alone. The combination also helps in significantly improving eating habits along with enhancing the quality of life of patients. Oxycodone hydrochloride is known for having a strong affinity for opioid receptors in the spinal cord and brain, allowing it to deliver effective analgesic effects on bone metastases. Many clinicians have combined oxycodone hydrochloride and radiotherapy for treating moderate to severe pain caused due to bone metastases of malignant tumors. This combination has aided them in achieving a combination of long-term and short-term analgesic effects.
For instance, according to the estimates of CONQUER CANCER (The ASCO Foundation), neck and head cancer accounts for approximately 4% of all cancer cases in the United States. It was estimated that in 2023, 66,930 individuals living in the United States will be diagnosed with neck and head cancers. The rising cases of neck and head cancer in various regions across the globe are therefore propelling the requirement for oxycodone hydrochloride. The administration of prolonged-release tablets is derived from this chemical during radiotherapy, effectively reducing the pain that is caused due to radiation-induced oral mucositis for patients suffering from neck and head cancer. Thus, boosting the requirement for oxycodone hydrochloride and supporting the growth of the market.
Rising Number of Surgeries Boost Global Oxycodone Hydrochloride Market Demand
The mechanism of action of oxycodone is similar to that of the other opioids which includes binding to a receptor, inhibiting hyperpolarization of neurons and adenylyl-cyclase, and reducing impulsiveness. Oxycodone hydrochloride is also used as a preemptive analgesia in various gynecological procedures such as gynecological laparoscopic surgery. Oxycodone hydrochloride is an opioid receptor agonist that is mixed-type and has agonistic effects on both μ and κ receptors. It primarily works for the smooth muscles and central nervous system, allowing the effective treatment of visceral pain as compared to other potent opioids. As a result, the adoption of oxycodone hydrochloride is increasing in surgeries.
For instance, according to the estimates of the Lancet Commission on global surgery, approximately 5,000 surgeries per 100,000 population, per year are required. The estimations show that in India, 3,646 surgeries are required per year, per 100,000 population. Of these 13% are ophthalmological surgeries, 20% are gynecological and obstetric surgeries, and 26% are general surgical procedures. This increase is augmenting the requirement for oxycodone hydrochloride as it is used for pain management in moderate and minor surgeries and postoperative pain. Due to such applications and advantages offered by the chemical, the demand for oxycodone hydrochloride is increasing, supporting the expansion of the market.
North America Holds a Significant Share of the Market
The increasing prevalence of head and neck cancer in the region and the surging requirement for different surgical procedures are major factors supporting the growth of the North America oxycodone hydrochloride market. The augmenting consumption of prescription drugs in the region for effectively managing pain caused by various conditions such as cancer and neuralgia is another major factor propelling the requirement for oxycodone hydrochloride in North America. Additionally, the Food and Drug Administration (FDA) has also approved various prescription drugs that use oxycodone hydrochloride for pain management. The growing requirement for surgical procedures is also boosting the requirement for oxycodone hydrochloride as it is deployed for treating postoperative pain. For instance, according to the estimates of Johns Hopkins Medicine, the most common surgical operations conducted in the United States include appendectomy, breast biopsy, coronary artery bypass, and cholecystectomy. Thus, increasing the demand for oxycodone hydrochloride to ensure the production of drugs that aid patients in effective management of postoperative pain.
Controlled Release Accounts for Significant Global Oxycodone Hydrochloride Market Share
The segment's growth can be attributed to the increasing utilization of controlled-release tablets for relieving severe to moderate persistent pain in situations where other forms of pain treatment solutions have been rendered ineffective. These products are also deployed in situations where continuous analgesics are required for an extended duration of time. The oxycodone hydrochloride-controlled release tablets are opioid analgesics that are orally administered and available in 20 mg and 10 mg strengths. The tablets contain various inactive ingredients including titanium dioxide, ammonio methacrylate copolymer, polyethylene glycol 400, sorbic acid, triacetin, sodium hydroxide, povidone, magnesium stearate, lactose, Hypromellose, talc, and stearyl alcohol. For instance, tablets with 20 mg strength also contain red iron oxide and polysorbate 80 and the tablet with 10 mg strength also contains hydroxypropyl cellulose. These controlled-release tablets are designed to ensure the controlled delivery of oxycodone over twelve hours. The release of oxycodone from these tablets is independent of pH and the oxycodone released from the tablets is absorbed at a bioavailability of 60%-87%. Thus, utilization of controlled-release tablets is boosting the segment's expansion and supporting the global oxycodone hydrochloride market growth.
Increased Product Requirement for Medicine Manufacturing Supports Market Expansion
The rising incidences of cancer and the increasing requirement for surgical procedures for the treatment and management of various health conditions is boosting the demand for oxycodone hydrochloride. This augmentation can be attributed to the effective pain management offered by the chemical in both minor surgical procedures and postoperative pain. The growing emphasis on patient care in various healthcare facilities is another major factor bolstering the requirement for oxycodone hydrochloride-based medication for effective management of severe and acute pain, propelling the expansion of the segment and boosting the global oxycodone hydrochloride market growth. The surge in the aging populace is another major factor supporting the growth of the segment as the older population is more susceptible to various pain-causing disorders and requires various surgical procedures to ensure proper management and treatment of various health conditions. For instance, according to a research article published by researchers from the Department of Urology and Department of Population Health Sciences, Geisinger, Danville, PA, approximately 4 million surgical procedures are performed every year in individuals aged 65 or older. Thus, bolstering the requirement for oxycodone hydrochloride for manufacturing medicine for the management of pain post-surgical procedures.
Future Market Scenario (2024–2031F)
According to the global oxycodone hydrochloride market analysis, various interventional studies are underway to evaluate the safety, efficacy, tolerability, and pharmacokinetic effects of oxycodone. For instance, Zuyderland Medisch Centrum is currently conducting a study to identify the impact of intercostal nerve cryoablation on the length of the postoperative hospital stay in comparison to the standard pain management of pectus excavatum patients. The randomized, single-center, unblinded, and prospective clinical trial is estimated to reach completion by September 2025. The increase in the number of such trials is propelling the requirement for oxycodone hydrochloride and aiding in evaluating the safety and efficacy of the chemical, thus increasing product applications and boosting the growth of the market.
Report Scope
“Oxycodone Hydrochloride Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global oxycodone hydrochloride market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
Report Attribute |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2017-2022 |
Forecast Period |
2024-2031F |
Projected Growth Rate |
CAGR of 5.1% between 2024 and 2031F |
Revenue Forecast in 2031 |
USD 627.51 million |
Segments Covered |
Purity, Type, Form, Application |
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
Key Companies Profiled |
Veranova Bidco, L.P., Euroapi SA, Noramco, Inc., Saneca Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Chattem Chemicals Inc., Tiefenbacher API + Ingredients GmbH & Co. KG, Sigma-Aldrich (Merck Group), Delphis Pharmaceutical India, PluviaEndo |
Customization Scope |
15% free report customization with purchase |
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global oxycodone hydrochloride market has been segmented into the following categories:
· By Purity
o Less than 98%
o 98% to 99%
o More than 99%
· By Type
o Immediate Release
o Controlled Release
· By Form
o Solid
o Liquid
· By Application
o Medicine Manufacturing
o Research and Academics
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East & Africa
Key Players Landscape and Outlook
The expansion of the market is supported by the rising investments by various companies in research and development activities. Furthermore, they are collaborating with other companies and organizations to support their R&D activities, which is expected to provide lucrative growth opportunities for the market. Various studies are conducted globally to evaluate the possible health benefits resulting from oxycodone hydrochloride.
For instance, OpalGenix, Inc., a developer of genetic tests for pain management and precision opioids is sponsoring an observational study to evaluate the effects of interactions and multiple genes on methadone and oxycodone’s pharmacokinetics. The study is expected to conclude in September 2024. Such studies aid in determining the working and efficacy of the pain management solutions that deploy oxycodone hydrochloride, thus boosting the product demand and augmenting the market expansion.
Key Players Operating in Global Oxycodone Hydrochloride Market are:
· Veranova Bidco, L.P.
· Euroapi SA
· Noramco, Inc.
· Saneca Pharmaceuticals
· Sun Pharmaceutical Industries Ltd.
· Chattem Chemicals Inc.
· Tiefenbacher API + Ingredients GmbH & Co. KG
· Sigma-Aldrich (Merck Group)
· Delphis Pharmaceutical India
· PluviaEndo
Markets and Data report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global oxycodone hydrochloride market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Voice of Customer
4.1. Market Awareness and Product Information
4.2. Brand Awareness and Loyalty
4.3. Factors Considered in Purchase Decision
4.3.1.Brand Name
4.3.2.Quality
4.3.3.Quantity
4.3.4.Price
4.3.5.Product Specification
4.3.6.Form Specification
4.3.7.Shelf Life
4.3.8.Availability of Product
4.4. Frequency of Purchase
4.5. Medium of Purchase
5. Global Oxycodone Hydrochloride Market Outlook, 2017-2031F
5.1. Market Size & Forecast
5.1.1.By Value
5.1.2.By Volume
5.2. By Purity
5.2.1.Less than 98%
5.2.2.98% to 99%
5.2.3.More than 99%
5.3. By Type
5.3.1.Immediate Release
5.3.2.Controlled Release
5.4. By Form
5.4.1.Solid
5.4.2.Liquid
5.5. By Application
5.5.1.Medicine Manufacturing
5.5.2.Research and Academics
5.5.3.Others
5.6. By Region
5.6.1.North America
5.6.2.South America
5.6.3.Europe
5.6.4.Asia-Pacific
5.6.5.Middle East & Africa
5.7. By Company Market Share (%), 2023
6. Global Oxycodone Hydrochloride Market Outlook, By Region, 2017-2031F
6.1. North America*
6.1.1.Market Size & Forecast
6.1.1.1. By Value
6.1.1.2. By Volume
6.1.2.By Purity
6.1.2.1. Less than 98%
6.1.2.2. 98% to 99%
6.1.2.3. More than 99%
6.1.3.By Type
6.1.3.1. Immediate Release
6.1.3.2. Controlled Release
6.1.4.By Form
6.1.4.1. Solid
6.1.4.2. Liquid
6.1.5.By Application
6.1.5.1. Medicine Manufacturing
6.1.5.2. Research and Academics
6.1.5.3. Others
6.1.6.United States*
6.1.6.1. Market Size & Forecast
6.1.6.1.1. By Value
6.1.6.1.2. By Volume
6.1.6.2. By Purity
6.1.6.2.1. Less than 98%
6.1.6.2.2. 98% to 99%
6.1.6.2.3. More than 99%
6.1.6.3. By Type
6.1.6.3.1. Immediate Release
6.1.6.3.2. Controlled Release
6.1.6.4. By Form
6.1.6.4.1. Solid
6.1.6.4.2. Liquid
6.1.6.5. By Application
6.1.6.5.1. Medicine Manufacturing
6.1.6.5.2. Research and Academics
6.1.6.5.3. Others
6.1.7.Canada
6.1.8.Mexico
*All segments will be provided for all regions and countries covered
6.2. Europe
6.2.1.Germany
6.2.2.France
6.2.3.Italy
6.2.4.United Kingdom
6.2.5.Russia
6.2.6.Netherlands
6.2.7.Spain
6.2.8.Turkey
6.2.9.Poland
6.3. Asia-Pacific
6.3.1.India
6.3.2.China
6.3.3.Japan
6.3.4.Australia
6.3.5.Vietnam
6.3.6.South Korea
6.3.7.Indonesia
6.3.8.Philippines
6.4. South America
6.4.1.Brazil
6.4.2.Argentina
6.5. Middle East & Africa
6.5.1.Saudi Arabia
6.5.2.UAE
6.5.3.South Africa
7. Supply Side Analysis
7.1. Capacity, By Company
7.2. Production, By Company
7.3. Operating Efficiency, By Company
7.4. Key Plant Locations (Up to 25)
8. Market Mapping, 2023
8.1. By Purity
8.2. By Type
8.3. By Form
8.4. By Application
8.5. By Region
9. Macro Environment and Industry Structure
9.1. Supply Demand Analysis
9.2. Import Export Analysis
9.3. Value Chain Analysis
9.4. PESTEL Analysis
9.4.1.Political Factors
9.4.2.Economic System
9.4.3.Social Implications
9.4.4.Technological Advancements
9.4.5.Environmental Impacts
9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
9.5. Porter’s Five Forces Analysis
9.5.1.Supplier Power
9.5.2.Buyer Power
9.5.3.Substitution Threat
9.5.4.Threat from New Entrant
9.5.5.Competitive Rivalry
10. Market Dynamics
10.1. Growth Drivers
10.2. Growth Inhibitors (Challenges and Restraints)
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1. Veranova Bidco, L.P.
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.2. Euroapi SA
14.3. Noramco, Inc.
14.4. Saneca Pharmaceuticals
14.5. Sun Pharmaceutical Industries Ltd.
14.6. Chattem Chemicals Inc.
14.7. Tiefenbacher API + Ingredients GmbH & Co. KG
14.8. Sigma-Aldrich (Merck Group)
14.9. Delphis Pharmaceutical India
14.10. PluviaEndo
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
15. Strategic Recommendations
16. About Us & Disclaimer
List of Figures
Figure 1. Global Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 2. Global Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 3. Global Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 4. Global Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 5. Global Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 6. Global Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 7. Global Oxycodone Hydrochloride Market Share (%), By Region, 2017-2031F
Figure 8. North America Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 9. North America Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 10. North America Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 11. North America Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 12. North America Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 13. North America Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 14. North America Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 15. United States Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 16. United States Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 17. United States Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 18. United States Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 19. United States Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 20. United States Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 21. Canada Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 22. Canada Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 23. Canada Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 24. Canada Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 25. Canada Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 26. Canada Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 27. Mexico Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 28. Mexico Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 29. Mexico Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 30. Mexico Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 31. Mexico Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 32. Mexico Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 33. Europe Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 34. Europe Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 35. Europe Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 36. Europe Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 37. Europe Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 38. Europe Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 39. Europe Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 40. Germany Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 41. Germany Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 42. Germany Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 43. Germany Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 44. Germany Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 45. Germany Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 46. France Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 47. France Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 48. France Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 49. France Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 50. France Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 51. France Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 52. Italy Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 53. Italy Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 54. Italy Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 55. Italy Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 56. Italy Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 57. Italy Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 58. United Kingdom Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 59. United Kingdom Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 60. United Kingdom Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 61. United Kingdom Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 62. United Kingdom Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 63. United Kingdom Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 64. Russia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 65. Russia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 66. Russia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 67. Russia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 68. Russia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 69. Russia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 70. Netherlands Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 71. Netherlands Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 72. Netherlands Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 73. Netherlands Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 74. Netherlands Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 75. Netherlands Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 76. Spain Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 77. Spain Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 78. Spain Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 79. Spain Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 80. Spain Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 81. Spain Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 82. Turkey Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 83. Turkey Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 84. Turkey Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 85. Turkey Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 86. Turkey Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 87. Turkey Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 88. Poland Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 89. Poland Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 90. Poland Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 91. Poland Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 92. Poland Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 93. Poland Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 94. South America Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 95. South America Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 96. South America Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 97. South America Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 98. South America Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 99. South America Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 100. South America Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 102. Brazil Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 103. Brazil Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 104. Brazil Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 105. Brazil Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 106. Brazil Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 107. Argentina Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 108. Argentina Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 109. Argentina Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 110. Argentina Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 111. Argentina Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 112. Argentina Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 113. Asia-Pacific Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 114. Asia-Pacific Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 115. Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 116. Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 117. Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 118. Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 119. Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 120. India Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 121. India Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 122. India Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 123. India Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 124. India Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 125. India Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 126. China Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 127. China Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 128. China Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 129. China Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 130. China Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 131. China Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 132. Japan Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 133. Japan Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 134. Japan Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 135. Japan Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 136. Japan Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 137. Japan Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 138. Australia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 139. Australia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 140. Australia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 141. Australia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 142. Australia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 143. Australia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 144. Vietnam Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 145. Vietnam Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 146. Vietnam Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 147. Vietnam Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 148. Vietnam Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 149. Vietnam Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 150. South Korea Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 151. South Korea Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 152. South Korea Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 153. South Korea Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 154. South Korea Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 155. South Korea Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 156. Indonesia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 157. Indonesia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 158. Indonesia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 159. Indonesia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 160. Indonesia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 161. Indonesia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 162. Philippines Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 163. Philippines Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 164. Philippines Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 165. Philippines Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 166. Philippines Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 167. Philippines Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 168. Middle East & Africa Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 169. Middle East & Africa Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 170. Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 171. Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 172. Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 173. Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 174. Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 176. Saudi Arabia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 177. Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 178. Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 179. Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 180. Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 181. UAE Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 182. UAE Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 183. UAE Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 184. UAE Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 185. UAE Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 186. UAE Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 187. South Africa Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 188. South Africa Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 189. South Africa Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 190. South Africa Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 191. South Africa Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 192. South Africa Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 193. By Purity Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 194. By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 195. By Form Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 196. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
There is an increased demand for dual-energy x-ray absorptiometry (DXA) in the global bone densitometers market. Also, increasing prevalence of osteoporosis, growing geriatric population, technological advancements, and collaborative research and new....Read More
Published on
May 2024
4,500
Global medical terminology software market is expected to witness significant growth over the forecast period owing to an increase in measures for reducing clinical errors and rising investments towards the development of technologically advanced sol....Read More
Published on
May 2024
4,500
Global legionella testing market will witness significant growth owing to the rapid expansion of the healthcare sector, increasing awareness about the importance of regular legionella testing, and rising prevalence of legionella related illnesses.....Read More
Published on
May 2024
4,500
Global endoluminal suturing devices market is expected to witness significant growth over the forecast period owing to rise in the number of cases of gastrointestinal cancer and increasing preference for non-invasive procedures.....Read More
Published on
May 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US